Papp L Roy & Associates Abb Vie Inc. Transaction History

Papp L Roy & Associates

$810 Million
Q4 2024

A detailed history of Papp L Roy & Associates transactions in Abb Vie Inc. stock. As of the latest transaction made, Papp L Roy & Associates holds 7,692 shares of ABBV stock, worth $1.46 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,692

Previous 7,842 1.91%

Holding current value

$1.46 Million

Previous $1.55 Million 11.76%

% of portfolio

0.17%

Previous 0.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$164.99 - $203.87 $24,748 - $30,580	-150 Reduced 1.91%	7,692 $1.37 Million
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $8,192 - $9,966	-50 Reduced 0.63%	7,842 $1.55 Million
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $9,287 - $10,845	60 Added 0.77%	7,892 $1.35 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $1,118 - $1,274	7 Added 0.09%	7,832 $1.43 Million
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $2,889 - $3,254	21 Added 0.27%	7,825 $1.21 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $6,679 - $7,732	-50 Reduced 0.64%	7,804 $1.16 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $28,922 - $33,308	-200 Reduced 2.48%	7,854 $1.25 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $11,618 - $13,933	-84 Reduced 1.03%	8,054 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $26,842 - $30,786	-200 Reduced 2.4%	8,138 $1.09 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $7,569 - $9,622	-55 Reduced 0.66%	8,338 $1.28 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $107 - $135	1 Added 0.01%	8,393 $1.14 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $24,472 - $27,779	-230 Reduced 2.67%	8,392 $905,000
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $263,130 - $293,142	2,501 Added 40.86%	8,622 $971,000
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $286,337 - $315,223	-2,799 Reduced 31.38%	6,121 $662,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $80 - $108	1 Added 0.01%	8,920 $956,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $85 - $100	1 Added 0.01%	8,919 $781,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $73 - $98	1 Added 0.01%	8,918 $876,000
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $16,060 - $24,349	-249 Reduced 2.72%	8,917 $679,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $32,097 - $40,161	-445 Reduced 4.63%	9,166 $812,000
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $15,996 - $19,232	-254 Reduced 2.57%	9,611 $728,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $109,324 - $139,742	1,664 Added 20.29%	9,865 $717,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $48,598 - $57,197	-630 Reduced 7.13%	8,201 $661,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $33,086 - $40,804	425 Added 5.06%	8,831 $814,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $68,639 - $91,914	-746 Reduced 8.15%	8,406 $796,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $11,553 - $12,669	129 Added 1.43%	9,152 $885,000
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $630,256 - $805,032	9,023	9,023 $802,000

Others Institutions Holding ABBV

# of Institutions

3,894

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $336B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Abb Vie Inc. Transaction History